Impact of anti-citrullinated protein antibody on tumor necrosis factor inhibitor or abatacept response in patients with rheumatoid arthritis

OBJECTIVE: To assess the impact of anti-citrullinated protein antibody (ACPA) serostatus on response to treatment with either tumor necrosis factor inhibitors (TNFi) or abatacept in patients with rheumatoid arthritis (RA). METHODS: Data was obtained from the Optimizing Patient outcomes in Australian...

Descripción completa

Detalles Bibliográficos
Autores principales: Tymms, Kathleen, Butcher, Belinda, Smith, Tegan, Littlejohn, Geoffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133894/
https://www.ncbi.nlm.nih.gov/pubmed/32966190
http://dx.doi.org/10.5152/eurjrheum.2020.20024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133894/
https://www.ncbi.nlm.nih.gov/pubmed/32966190
http://dx.doi.org/10.5152/eurjrheum.2020.20024

Ejemplares similares